Cancer Research Landon Prizes for Basic and Translational Cancer Research  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 3861-3866, July 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sharma, R. C.
Right arrow Articles by Schimke, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharma, R. C.
Right arrow Articles by Schimke, R. T.

Enhancement of the Frequency of Methotrexate Resistance by {gamma}-Radiation in Chinese Hamster Ovary and Mouse 3T6 Cells1

Rakesh C. Sharma and Robert T. Schimke

Department of Biological Sciences, Stanford University, Stanford, California 94305

We have studied the effects of {gamma}-radiation on the frequency of methotrexate resistance and dihydrofolate reductase gene amplification. {gamma}-Irradiation of Chinese hamster ovary cells resulted in enhancement of the frequency of methotrexate resistant colonies (maximum enhancement: 2000-fold after 1000 rads). The enhancement of methotrexate resistance was dependent on the dose of {gamma}-radiation and increased with time after irradiation; a maximum enhancement was observed when methotrexate was added 18 h after irradiation. Methotrexate resistant clones of Chinese hamster ovary cells showed no increase in dihydrofolate reductase gene copy number but were found to be defective in methotrexate transport. However, when these experiments were extended to 3T6 murine cells, 54% of nonirradiated and 44% of {gamma}-radiation induced methotrexate resistant clones showed an increase in dihydrofolate reductase gene copy number. These results suggest that the cells that survive irradiation have a very high probability of becoming methotrexate resistant and may explain why some malignant tumors (e.g., head and neck cancer) either do not respond or respond poorly to chemotherapy if the patient had prior radiotherapy.

1 This work was supported by Research Grant CA-16318 from the National Cancer Institute.

Received 11/15/88. Revised 3/14/89. Accepted 4/12/89.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Yan, H. Wang, Y. Peng, Y. Hu, H. Wang, X. Zhang, Q. Chen, J. S. Bedford, M. W. Dewhirst, and C.-Y. Li
A unique role of the DNA fragmentation factor in maintaining genomic stability
PNAS, January 31, 2006; 103(5): 1504 - 1509.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. G. Paulson, A. Almasan, L. L. Brody, and G. M. Wahl
Gene Amplification in a p53-Deficient Cell Line Requires Cell Cycle Progression under Conditions That Generate DNA Breakage
Mol. Cell. Biol., May 1, 1998; 18(5): 3089 - 3100.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.